Messoud Ashina
Messoud Ashina
Danish Headache Center, Department of Neurology, Rigshospitalet Glostrup, University of Copenhagen
Verified email at - Homepage
Cited by
Cited by
Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
S Tepper, M Ashina, U Reuter, JL Brandes, D Doležil, S Silberstein, ...
The Lancet Neurology 16 (6), 425-434, 2017
Origin of pain in migraine: evidence for peripheral sensitisation
J Olesen, R Burstein, M Ashina, P Tfelt-Hansen
The Lancet Neurology 8 (7), 679-690, 2009
ARISE: a phase 3 randomized trial of erenumab for episodic migraine
DW Dodick, M Ashina, JL Brandes, D Kudrow, M Lanteri-Minet, V Osipova, ...
Cephalalgia 38 (6), 1026-1037, 2018
Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura
JM Hansen, AW Hauge, J Olesen, M Ashina
Cephalalgia 30 (10), 1179-1186, 2010
PACAP38 induces migraine-like attacks in patients with migraine without aura
HW Schytz, S Birk, T Wienecke, C Kruuse, J Olesen, M Ashina
Brain 132 (1), 16-25, 2009
A systematic comparison of motion artifact correction techniques for functional near-infrared spectroscopy
RJ Cooper, J Selb, L Gagnon, D Phillip, HW Schytz, HK Iversen, M Ashina, ...
Frontiers in neuroscience 6, 147, 2012
Migraine: epidemiology and systems of care
M Ashina, Z Katsarava, TP Do, DC Buse, P Pozo-Rosich, A Özge, ...
The Lancet 397 (10283), 1485-1495, 2021
Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled …
DW Dodick, PJ Goadsby, SD Silberstein, RB Lipton, J Olesen, M Ashina, ...
The lancet neurology 13 (11), 1100-1107, 2014
Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
H Sun, DW Dodick, S Silberstein, PJ Goadsby, U Reuter, M Ashina, ...
The Lancet Neurology 15 (4), 382-390, 2016
European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
S Sacco, L Bendtsen, M Ashina, U Reuter, G Terwindt, DD Mitsikostas, ...
The journal of headache and pain 20, 1-33, 2019
Migraine and the trigeminovascular system—40 years and counting
M Ashina, JM Hansen, TP Do, A Melo-Carrillo, R Burstein, MA Moskowitz
The Lancet Neurology 18 (8), 795-804, 2019
Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind …
MD Ferrari, HC Diener, X Ning, M Galic, JM Cohen, R Yang, M Mueller, ...
The Lancet 394 (10203), 1030-1040, 2019
Migraine and structural changes in the brain: a systematic review and meta-analysis
A Bashir, RB Lipton, S Ashina, M Ashina
Neurology 81 (14), 1260-1268, 2013
Magnetic resonance angiography of intracranial and extracranial arteries in patients with spontaneous migraine without aura: a cross-sectional study
FM Amin, MS Asghar, A Hougaard, AE Hansen, VA Larsen, ...
The Lancet Neurology 12 (5), 454-461, 2013
Evidence for a vascular factor in migraine
MS Asghar, AE Hansen, FM Amin, RJ Van Der Geest, P Koning, ...
Annals of neurology 69 (4), 635-645, 2011
Eptinezumab in episodic migraine: a randomized, double-blind, placebo-controlled study (PROMISE-1)
M Ashina, J Saper, R Cady, BA Schaeffler, DM Biondi, J Hirman, ...
Cephalalgia 40 (3), 241-254, 2020
Diagnosis and management of migraine in ten steps
AK Eigenbrodt, H Ashina, S Khan, HC Diener, DD Mitsikostas, AJ Sinclair, ...
Nature Reviews Neurology 17 (8), 501-514, 2021
Nitric oxide synthase inhibition in migraine
LH Lassen, M Ashina, I Christiansen, V Ulrich, J Olesen
The Lancet 349 (9049), 401-402, 1997
Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults
C Tassorelli, HC Diener, DW Dodick, SD Silberstein, RB Lipton, M Ashina, ...
Cephalalgia 38 (5), 815-832, 2018
Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine
A Rahmann, T Wienecke, JM Hansen, J Fahrenkrug, J Olesen, M Ashina
Cephalalgia 28 (3), 226-236, 2008
The system can't perform the operation now. Try again later.
Articles 1–20